Evidence map›Paper›PMID 37670826›Full record

ArticleFrontiers in public health2023

Evaluation of online videos to engage viewers and support decision-making for COVID-19 vaccination: how narratives and race/ethnicity enhance viewer experiences.

Holly B Schuh, Rajiv N Rimal, Robert F Breiman, Peter Z Orton, Matthew Z Dudley, Lee-Sien Kao, Rikki H Sargent, Shaelyn Laurie, Leo F Weakland, James V Lavery and 7 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Holly B SchuhDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Rajiv N RimalDepartment of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Robert F BreimanHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Peter Z OrtonIndependent Researcher, Mebane, NC, United States.
Matthew Z DudleyInstitute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Lee-Sien KaoIdeas42, New York, NY, United States.
Rikki H SargentRIWI Corp., Toronto, ON, Canada.
Shaelyn LaurieRIWI Corp., Toronto, ON, Canada.
Leo F WeaklandCenter for Global Health Innovation, Atlanta, GA, United States.
James V LaveryHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Walter A OrensteinDepartment of Medicine, Emory University, School of Medicine, Atlanta, GA, United States.
Janesse BrewerInstitute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Amelia M JamisonDepartment of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Jana ShawDivision of Infectious Diseases, Department of Pediatrics, The State University of New York (SUNY) Upstate Medical University, Syracuse, NY, United States.
Robina Josiah WillockDepartment of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, GA, United States.
Deborah A GustDepartment of Psychology, Education Division, Gwinnett Technical College, Lawrenceville, GA, United States.
Daniel A SalmonInstitute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Vaccine hesitancy has hampered the control of COVID-19 and other vaccine-preventable diseases. Methods: We conducted a national internet-based, quasi-experimental study to evaluate COVID-19 vaccine informational videos. Participants received an informational animated video paired with the randomized assignment of (1) a credible source (differing race/ethnicity) and (2) sequencing of a personal narrative before or after the video addressing their primary vaccine concern. We examined viewing time and asked video evaluation questions to those who viewed the full video. Results: Among 14,235 participants, 2,422 (17.0%) viewed the full video. Those who viewed a personal story first (concern video second) were 10 times more likely to view the full video ( Conclusion: Using peer-delivered, personal narrative, and/or racially congruent credible sources to introduce and deliver vaccine safety information may improve the openness of vaccine message recipients to messages and engagement.

Indexed as

COVID-19COVID-19 VaccinesEthnicityHumansIntentionVaccinationCOVID-19 VaccinesCOVID-19internet-based interventionpersonal narrativerace/ethnic congruencevaccine decision-makingvaccine hesitancy

Identifiers

PMID37670826
PMCPMC10475941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.